FDG-PET/CT versus contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients

被引:0
|
作者
Riedl, Christopher
Pinker, Katja
Ong, Leonard
Jochelson, Maxine S.
Ulaner, Gary
McArthur, Heather L.
Dickler, Maura N.
Weber, Wolfgang
机构
[1] Mem Sloan Kettering Canc Ctr, Mol Imaging & Therapy Serv, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
10.1200/jco.2015.33.15_suppl.1051
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1051
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT
    Kazuhiro Kitajima
    Koji Murakami
    Erena Yamasaki
    Yasushi Kaji
    Ichio Fukasawa
    Noriyuki Inaba
    Kazuro Sugimura
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 1912 - 1920
  • [32] [18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis
    Justet, Aurelien
    Laurent-Bellue, Astrid
    Thabut, Gabriel
    Dieudonne, Arnaud
    Debray, Marie-Pierre
    Borie, Raphael
    Aubier, Michel
    Lebtahi, Rachida
    Crestani, Bruno
    RESPIRATORY RESEARCH, 2017, 18
  • [33] Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT
    Kitajima, Kazuhiro
    Murakami, Koji
    Yamasaki, Erena
    Kaji, Yasushi
    Fukasawa, Ichio
    Inaba, Noriyuki
    Sugimura, Kazuro
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (10) : 1912 - 1920
  • [34] [18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis
    Aurélien Justet
    Astrid Laurent-Bellue
    Gabriel Thabut
    Arnaud Dieudonné
    Marie-Pierre Debray
    Raphael Borie
    Michel Aubier
    Rachida Lebtahi
    Bruno Crestani
    Respiratory Research, 18
  • [35] 18F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma
    Costelloe, Colleen M.
    Macapinlac, Horner A.
    Madewell, John E.
    Fitzgerald, Nancy E.
    Mawlawi, Osama R.
    Rohren, Eric M.
    Raymond, A. Kevin
    Lewis, Valerae O.
    Anderson, Peter M.
    Bassett, Roland L., Jr.
    Harrell, Robyn K.
    Marom, Edith M.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (03) : 340 - 347
  • [36] Diagnosing bone metastasis in recurrent breast cancer: dual time FDG-PET/CT compared to contrast enhanced CT and bone scintigraphy
    Hildebrandt, M. G.
    Ansholm, J.
    Gerke, O.
    Baun, C.
    Falch, K.
    Farahani, Z.
    Duvnjak, S.
    Larsen, L.
    Buskevica, I.
    Bektas, S.
    Alavi, A.
    Hoilund-Carlsen, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S625 - S625
  • [37] Diagnosis of distant recurrent breast cancer: head-to-head comparisons of FDG-PET/CT, contrast enhanced CT, and bone scintigraphy
    Hildebrandt, M. G.
    Gerke, O.
    Baun, C.
    Falch, K.
    Ansholm, J.
    Farahani, Z.
    Larsen, L.
    Duvnjak, S.
    Soe, K.
    Jylling, A. B.
    Ewertz, M.
    Alavi, A.
    Hoilund-Carlsen, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S613 - S613
  • [38] Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer
    Laura Evangelista
    Zora Baretta
    Lorenzo Vinante
    Anna Rita Cervino
    Michele Gregianin
    Cristina Ghiotto
    Giorgio Saladini
    Guido Sotti
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 293 - 301
  • [39] Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer
    Evangelista, Laura
    Baretta, Zora
    Vinante, Lorenzo
    Cervino, Anna Rita
    Gregianin, Michele
    Ghiotto, Cristina
    Saladini, Giorgio
    Sotti, Guido
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (02) : 293 - 301
  • [40] Radiomics Analysis of PET and CT Components of 18F-FDG PET/CT Imaging for Prediction of Progression-Free Survival in Advanced High-Grade Serous Ovarian Cancer
    Wang, Xihai
    Lu, Zaiming
    FRONTIERS IN ONCOLOGY, 2021, 11